Finally, various anti‐apoptosis proteins of the Bcl‐2 family such as pBcl‐2, Mcl‐1, Bcl‐XL, and XIAP10 should also be explored in order to fully improve cisplatin sensitivity in ovarian cancer treatment. This evidence concerns the gene BCL2 and ovarian carcinoma.